ArticleVaccines2022

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages.

Carina C Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.